Trial · NCT02679170
Adverse events158
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 158
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Elevated alanine aminotransferase | Investigations | ALK Treatment Sub-study | 8 | 91 | |
| other | Elevated alanine aminotransferase | Investigations | ROS1 Treatment Sub-study | 7 | 50 | |
| other | Elevated amylase | Investigations | ALK Treatment Sub-study | 1 | 91 | |
| other | Elevated amylase | Investigations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Elevated aspartate aminotransferase | Investigations | ALK Treatment Sub-study | 6 | 91 | |
| other | Elevated aspartate aminotransferase | Investigations | ROS1 Treatment Sub-study | 7 | 50 | |
| other | Increased blood alkaline phosphatase | Investigations | ALK Treatment Sub-study | 1 | 91 | |
| other | Increased blood alkaline phosphatase | Investigations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Elevated Gamma glutamyl transferase | Investigations | ALK Treatment Sub-study | 1 | 91 | |
| other | Elevated Gamma glutamyl transferase | Investigations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Increased QT Interval electrocardiography | Investigations | ALK Treatment Sub-study | 1 | 91 | |
| other | Increased QT Interval electrocardiography | Investigations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Elevated Transaminases | Investigations | ALK Treatment Sub-study | 1 | 91 | |
| other | Elevated Transaminases | Investigations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Decreased weight | Investigations | ALK Treatment Sub-study | 0 | 91 | |
| other | Decreased weight | Investigations | ROS1 Treatment Sub-study | 1 | 50 | |
| other | Oesophagic candidiasis | Infections and infestations | ALK Treatment Sub-study | 1 | 91 | |
| other | Oesophagic candidiasis | Infections and infestations | ROS1 Treatment Sub-study | 0 | 50 | |
| other | Candidiasis infection | Infections and infestations | ALK Treatment Sub-study | 1 | 91 | |
| other | Candidiasis infection | Infections and infestations | ROS1 Treatment Sub-study | 0 | 50 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02679170/events